This company listing is no longer active
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
McKesson Europe Bilan de santé
Santé financière contrôle des critères 5/6
McKesson Europe has a total shareholder equity of €2.5B and total debt of €8.3M, which brings its debt-to-equity ratio to 0.3%. Its total assets and total liabilities are €5.1B and €2.6B respectively. McKesson Europe's EBIT is €69.0M making its interest coverage ratio 5.2. It has cash and short-term investments of €1.9B.
Informations clés
0.3%
Ratio d'endettement
€8.30m
Dette
| Ratio de couverture des intérêts | 5.2x |
| Argent liquide | €1.91b |
| Fonds propres | €2.52b |
| Total du passif | €2.58b |
| Total des actifs | €5.10b |
Mises à jour récentes de la santé financière
Recent updates
Estimating The Fair Value Of McKesson Europe AG (HMSE:CLS1)
Dec 23
These Return Metrics Don't Make McKesson Europe (HMSE:CLS1) Look Too Strong
Sep 01These Return Metrics Don't Make McKesson Europe (HMSE:CLS1) Look Too Strong
May 19McKesson Europe (HMSE:CLS1) Could Be Struggling To Allocate Capital
Jan 27Capital Allocation Trends At McKesson Europe (HMSE:CLS1) Aren't Ideal
Sep 07McKesson Europe (HMSE:CLS1) Will Be Looking To Turn Around Its Returns
Apr 29What You Need To Know About McKesson Europe AG's (HMSE:CLS1) Investor Composition
Mar 20Is McKesson Europe AG (HMSE:CLS1) A Risky Dividend Stock?
Feb 13
Analyse de la situation financière
Passif à court terme: CLS1's short term assets (€4.2B) exceed its short term liabilities (€2.3B).
Passif à long terme: CLS1's short term assets (€4.2B) exceed its long term liabilities (€304.5M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: CLS1 has more cash than its total debt.
Réduire la dette: CLS1's debt to equity ratio has reduced from 69.3% to 0.3% over the past 5 years.
Couverture de la dette: CLS1's debt is not well covered by operating cash flow (10.8%).
Couverture des intérêts: CLS1's interest payments on its debt are well covered by EBIT (5.2x coverage).